Molecular structure of Cordycepin 5′-triphosphate sodium salt, CAS Number: 71997-32-5
Cordycepin 5′-triphosphate sodium salt (CAS 71997-32-5)
Alternate Names:
3′-deoxyadenosine-5′-triphosphate sodium salt; 3′-dGTP; 3′-deoxy-ATP
Application:
Cordycepin 5′-triphosphate sodium salt is used for 3′-end labeling of RNA
CAS Number:
71997-32-5
Molecular Weight:
514.17
Molecular Formula:
C10H16N5O12P3•Na
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Cordycepin 5′-triphosphate sodium salt is incorporated into nucleic acid by poly(A) polymerase. Since it lacks a 3′-hydroxyl group chain production, Cordycepin 5′-triphosphate can be used for 3′-end labeling of RNA. It is a nucleotide derivative that can inhibit DNA and RNA synthesis, as well as the production of cellular energy, by blocking relevant enzymes. It also exhibits antiviral properties by suppressing the replication of the hepatitis B virus and the herpes simplex virus.
Cordycepin 5′-triphosphate sodium salt (CAS 71997-32-5) References
- Peripheral administration of translation inhibitors reverses increased hyperalgesia in a model of chronic pain in the rat. | Ferrari, LF., et al. 2013. J Pain. 14: 731-8. PMID: 23664545
- Global regulation of promoter melting in naive lymphocytes. | Kouzine, F., et al. 2013. Cell. 153: 988-99. PMID: 23706737
- Role of nociceptor αCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats. | Ferrari, LF., et al. 2013. J Neurosci. 33: 11002-11. PMID: 23825405
- Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat. | Ferrari, LF., et al. 2014. J Pain. 15: 312-20. PMID: 24407022
- Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain. | Araldi, D., et al. 2015. J Neurosci. 35: 12502-17. PMID: 26354917
- Adenosine-A1 receptor agonist induced hyperalgesic priming type II. | Araldi, D., et al. 2016. Pain. 157: 698-709. PMID: 26588695
- Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming. | Araldi, D., et al. 2016. Pain. 157: 1773-1782. PMID: 27075428
- Permanganate/S1 Nuclease Footprinting Reveals Non-B DNA Structures with Regulatory Potential across a Mammalian Genome. | Kouzine, F., et al. 2017. Cell Syst. 4: 344-356.e7. PMID: 28237796
- Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals. | Araldi, D., et al. 2018. J Neurosci. 38: 2226-2245. PMID: 29431655
- Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat. | Araldi, D., et al. 2018. Neuroscience. 394: 60-71. PMID: 30342200
- Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity. | Ferrari, LF., et al. 2019. Neuroscience. 398: 64-75. PMID: 30529265
- Mammalian ALKBH1 serves as an N6-mA demethylase of unpairing DNA. | Zhang, M., et al. 2020. Cell Res. 30: 197-210. PMID: 32051560
- Opioid-Induced Hyperalgesic Priming in Single Nociceptors. | Khomula, EV., et al. 2021. J Neurosci. 41: 31-46. PMID: 33203743
- Genome-wide profiling reveals functional interplay of DNA sequence composition, transcriptional activity, and nucleosome positioning in driving DNA supercoiling and helix destabilization in C. elegans. | Krassovsky, K., et al. 2021. Genome Res. 31: 1187-202. PMID: 34168009
- Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues. | Daikopoulou, V., et al. 2021. Molecules. 26: PMID: 34200204
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cordycepin 5′-triphosphate sodium salt, 1 mg | sc-396713 | 1 mg | $189.00 |